Most people think of dermatology as the specialty for skin and rheumatology as the specialty for joints. What’s less widely understood is how frequently these two systems are affected by the same underlying disease process — and how much better outcomes are when they’re treated together.
If you’re dealing with a combination of skin rashes and joint pain, or if you’ve been diagnosed with a skin condition and are starting to notice musculoskeletal symptoms, this post is for you. We’ll walk through the most common conditions where skin and joints are both involved, explain why integrated care matters, and describe what that looks like at Dehesa Dermatology.
Why Skin and Joints Often Go Together
The skin and the joints share a common vulnerability: both are frequent targets of autoimmune and inflammatory diseases. The immune system, when dysregulated, can mistakenly attack the body’s own tissues — and the specific tissues affected depend on the particular disease, the patient’s genetics, and environmental triggers.
In many autoimmune conditions, the skin is the most visible manifestation of a process that is also occurring beneath the surface in the joints, muscles, blood vessels, or internal organs. The butterfly rash of lupus, the silvery plaques of psoriasis, and the periorbital heliotrope rash of dermatomyositis are all cutaneous windows into systemic inflammatory diseases with far-reaching consequences.
This is why dermatologists who understand rheumatology — and rheumatologists who understand dermatology — are invaluable for patients with complex autoimmune conditions. And it’s why Dehesa Dermatology was deliberately built as a multispecialty practice with both specialties under one roof.
Psoriatic Arthritis: The Most Common Skin-Joint Connection
Psoriatic arthritis (PsA) affects an estimated 30% of people with psoriasis — and in many patients, it develops years before the joint symptoms are formally recognized and linked to their skin disease. It is a seronegative inflammatory arthritis, meaning the typical rheumatoid arthritis antibodies (rheumatoid factor and anti-CCP) are usually absent, which can make diagnosis challenging in patients whose skin disease is mild or unrecognized.
PsA can affect any joint in the body but has several distinctive patterns: asymmetric oligoarthritis (a few joints on different sides of the body), distal interphalangeal joint involvement (the fingertip joints, rarely affected in rheumatoid arthritis), axial disease (spine and sacroiliac joints), dactylitis (sausage-like swelling of an entire finger or toe), and enthesitis (inflammation where tendons and ligaments attach to bone — particularly the Achilles tendon and plantar fascia).
Nail changes — pitting, onycholysis, and nail thickening — are a particularly important clue, present in up to 80% of PsA patients and far more common in psoriasis patients who develop joint disease than those who don’t.
According to the National Psoriasis Foundation, untreated PsA can cause progressive, irreversible joint damage within the first two years of disease onset. Early diagnosis and treatment are critical — and joint damage may be occurring even when symptoms feel manageable.
At Dehesa Dermatology, patients with psoriasis are routinely screened for joint symptoms, and our on-site rheumatologist Dr. Milena Cavalcante evaluates patients with suspected PsA directly. Treatment decisions for PsA are made collaboratively, recognizing that the right biologic or systemic therapy must address both skin and joint disease simultaneously.
Lupus: When the Butterfly Rash Is Just the Beginning
Systemic lupus erythematosus (SLE) is a complex multisystem autoimmune disease that affects the skin, joints, kidneys, heart, lungs, and nervous system. Its dermatologic manifestations are often the most visible and diagnostically significant feature of the disease.
The classic butterfly (malar) rash — a red, flat or slightly raised rash across the cheeks and nose, sparing the nasolabial folds — is the most recognizable feature and occurs in approximately 50% of SLE patients. It is photosensitive, meaning it worsens with sun exposure. Other cutaneous manifestations include discoid lupus (scarring, hyperpigmented plaques that can cause permanent hair loss), subacute cutaneous lupus (annular or psoriasiform photosensitive rashes), livedo reticularis (a net-like vascular pattern), and Raynaud’s phenomenon.
Joint involvement — typically a symmetric, non-erosive arthritis affecting the small joints of the hands and feet — occurs in approximately 90% of SLE patients and is often the symptom that brings patients to medical attention first.
Diagnosis of SLE requires meeting criteria across multiple organ systems, and the workup includes specific antibody testing (ANA, anti-dsDNA, anti-Smith, complement levels), urinalysis for kidney involvement, and other laboratory studies. Management requires integrated rheumatologic and dermatologic expertise — exactly the model at Dehesa Dermatology.
Dermatomyositis: When Muscle Weakness Comes with a Rash
Dermatomyositis is an inflammatory myopathy — a condition involving muscle inflammation — that has characteristic and diagnostically important skin findings. The heliotrope sign (a violaceous or purple discoloration around the eyelids, often with periorbital edema) and Gottron’s papules (flat-topped, red to violaceous papules over the knuckles of the fingers) are classic and highly specific features that dermatologists are trained to recognize.
Patients with dermatomyositis typically present with proximal muscle weakness (difficulty rising from chairs, climbing stairs, raising arms overhead) combined with the characteristic skin findings. Importantly, dermatomyositis is associated with an elevated risk of underlying malignancy — particularly in patients over 40 — making a thorough systemic evaluation essential at diagnosis.
Treatment involves systemic immunosuppression with agents including corticosteroids, methotrexate, azathioprine, and IVIG — the latter often administered intravenously. Our infusion therapy center at Dehesa Dermatology provides IVIG and other IV treatments for patients with dermatomyositis and related conditions.
Scleroderma: When Skin Thickening Points to Deeper Disease
Systemic sclerosis (scleroderma) causes progressive fibrosis (hardening and thickening) of the skin, blood vessels, and internal organs. Skin tightening — particularly of the hands, fingers, and face — is often the earliest and most noticeable manifestation. Raynaud’s phenomenon (exaggerated color changes in the fingers with cold or stress) frequently precedes the skin changes by years and is a critical early warning sign.
Scleroderma skin involvement is classified as limited (affecting the distal extremities and face) or diffuse (affecting the trunk and proximal limbs as well), with the diffuse form carrying a higher risk of lung, heart, and kidney complications. Dermatologic management focuses on skin care, wound care for digital ulcers, and treatment of calcinosis, while rheumatologic management addresses the systemic aspects of the disease.
Vasculitis: When the Rash Is a Blood Vessel Problem
Vasculitis — inflammation of blood vessels — can manifest in the skin as palpable purpura (raised, non-blanching red or purple spots), ulcerations, livedo reticularis, nodules, or urticarial plaques. Skin vasculitis may be a manifestation of a primary skin disease or a cutaneous sign of systemic vasculitis involving kidneys, lungs, nervous system, or other organs.
The workup for skin vasculitis involves skin biopsy, laboratory evaluation for underlying causes (infections, autoimmune conditions, medications), and urinalysis for kidney involvement. Management requires close collaboration between dermatology and rheumatology to address both skin and systemic disease.
The Integrated Care Advantage at Dehesa Dermatology
For all of these conditions, fragmented care — seeing a dermatologist on one end of town and a rheumatologist on the other, with limited communication between providers — leads to delayed diagnoses, conflicting treatment decisions, and suboptimal outcomes. At Dehesa Dermatology in Clovis, our integrated model with on-site rheumatologist Dr. Milena Cavalcante eliminates this fragmentation.
Patients with conditions spanning both specialties benefit from a single, coordinated care team that shares medical records, discusses cases directly, and selects systemic therapies with full awareness of both the skin and joint dimensions of the disease. Our on-site infusion therapy center also allows patients who require IV biologic therapy to receive those treatments in the same familiar, physician-supervised environment where they receive all of their specialist care.
If you have been diagnosed with psoriasis, lupus, scleroderma, dermatomyositis, or another autoimmune condition — or if you’re experiencing a combination of skin and joint symptoms that hasn’t been fully explained — we invite you to schedule a consultation at Dehesa Dermatology. Call (559) 951-9000 or visit dehesadermatology.com.
For further reading on the skin-joint connection in autoimmune disease, the American College of Rheumatology’s patient resources provide thorough, reliable information on the conditions discussed in this post.
